National Quality Forum Offers Adverse Event Reporting Guidelines
This article was originally published in The Gray Sheet
Executive Summary
State agencies, CMS and other organizations that report patient safety information should use validated, standard definitions of adverse events and vet the data to improve the quality and usefulness of patient safety reports, the National Quality Forum says
You may also be interested in...
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.